These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 17159223

  • 1. Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans, a major facilitator transporter involved in azole resistance.
    Rognon B, Kozovska Z, Coste AT, Pardini G, Sanglard D.
    Microbiology (Reading); 2006 Dec; 152(Pt 12):3701-3722. PubMed ID: 17159223
    [Abstract] [Full Text] [Related]

  • 2. Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters.
    Karababa M, Coste AT, Rognon B, Bille J, Sanglard D.
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3064-79. PubMed ID: 15273122
    [Abstract] [Full Text] [Related]

  • 3. Drug-induced regulation of the MDR1 promoter in Candida albicans.
    Harry JB, Oliver BG, Song JL, Silver PM, Little JT, Choiniere J, White TC.
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2785-92. PubMed ID: 15980350
    [Abstract] [Full Text] [Related]

  • 4. Transcriptional regulation of MDR1, encoding a drug efflux determinant, in fluconazole-resistant Candida albicans strains through an Mcm1p binding site.
    Riggle PJ, Kumamoto CA.
    Eukaryot Cell; 2006 Dec; 5(12):1957-68. PubMed ID: 17041190
    [Abstract] [Full Text] [Related]

  • 5. SAGA/ADA complex subunit Ada2 is required for Cap1- but not Mrr1-mediated upregulation of the Candida albicans multidrug efflux pump MDR1.
    Ramírez-Zavala B, Mogavero S, Schöller E, Sasse C, Rogers PD, Morschhäuser J.
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5102-10. PubMed ID: 24936593
    [Abstract] [Full Text] [Related]

  • 6. The bZip transcription factor Cap1p is involved in multidrug resistance and oxidative stress response in Candida albicans.
    Alarco AM, Raymond M.
    J Bacteriol; 1999 Feb; 181(3):700-8. PubMed ID: 9922230
    [Abstract] [Full Text] [Related]

  • 7. Multiple cis-acting sequences mediate upregulation of the MDR1 efflux pump in a fluconazole-resistant clinical Candida albicans isolate.
    Hiller D, Stahl S, Morschhäuser J.
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2300-8. PubMed ID: 16801405
    [Abstract] [Full Text] [Related]

  • 8. Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae.
    Coste AT, Ramsdale M, Ischer F, Sanglard D.
    Microbiology (Reading); 2008 May; 154(Pt 5):1491-1501. PubMed ID: 18451058
    [Abstract] [Full Text] [Related]

  • 9. A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance.
    de Micheli M, Bille J, Schueller C, Sanglard D.
    Mol Microbiol; 2002 Mar; 43(5):1197-214. PubMed ID: 11918807
    [Abstract] [Full Text] [Related]

  • 10. TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2.
    Coste AT, Karababa M, Ischer F, Bille J, Sanglard D.
    Eukaryot Cell; 2004 Dec; 3(6):1639-52. PubMed ID: 15590837
    [Abstract] [Full Text] [Related]

  • 11. Constitutive activation of the PDR16 promoter in a Candida albicans azole-resistant clinical isolate overexpressing CDR1 and CDR2.
    De Deken X, Raymond M.
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2700-3. PubMed ID: 15215129
    [Abstract] [Full Text] [Related]

  • 12. Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients.
    Looi CY, D' Silva EC, Seow HF, Rosli R, Ng KP, Chong PP.
    FEMS Microbiol Lett; 2005 Aug 15; 249(2):283-9. PubMed ID: 16006060
    [Abstract] [Full Text] [Related]

  • 13. The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans.
    Morschhäuser J, Barker KS, Liu TT, BlaB-Warmuth J, Homayouni R, Rogers PD.
    PLoS Pathog; 2007 Nov 15; 3(11):e164. PubMed ID: 17983269
    [Abstract] [Full Text] [Related]

  • 14. Differential requirement of the transcription factor Mcm1 for activation of the Candida albicans multidrug efflux pump MDR1 by its regulators Mrr1 and Cap1.
    Mogavero S, Tavanti A, Senesi S, Rogers PD, Morschhäuser J.
    Antimicrob Agents Chemother; 2011 May 15; 55(5):2061-6. PubMed ID: 21343453
    [Abstract] [Full Text] [Related]

  • 15. Induction of Candida albicans drug resistance genes by hybrid zinc cluster transcription factors.
    Schneider S, Morschhäuser J.
    Antimicrob Agents Chemother; 2015 Jan 15; 59(1):558-69. PubMed ID: 25385116
    [Abstract] [Full Text] [Related]

  • 16. Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor.
    Wirsching S, Michel S, Köhler G, Morschhäuser J.
    J Bacteriol; 2000 Jan 15; 182(2):400-4. PubMed ID: 10629186
    [Abstract] [Full Text] [Related]

  • 17. Expression of the CDR1 efflux pump in clinical Candida albicans isolates is controlled by a negative regulatory element.
    Gaur NA, Manoharlal R, Saini P, Prasad T, Mukhopadhyay G, Hoefer M, Morschhäuser J, Prasad R.
    Biochem Biophys Res Commun; 2005 Jun 24; 332(1):206-14. PubMed ID: 15896319
    [Abstract] [Full Text] [Related]

  • 18. SRE1 and SRE2 are two specific steroid-responsive modules of Candida drug resistance gene 1 (CDR1) promoter.
    Karnani N, Gaur NA, Jha S, Puri N, Krishnamurthy S, Goswami SK, Mukhopadhyay G, Prasad R.
    Yeast; 2004 Feb 24; 21(3):219-39. PubMed ID: 14968428
    [Abstract] [Full Text] [Related]

  • 19. Transcription initiation of genes associated with azole resistance in Candida albicans.
    Harry JB, Song JL, Lyons CN, White TC.
    Med Mycol; 2002 Feb 24; 40(1):73-81. PubMed ID: 11860016
    [Abstract] [Full Text] [Related]

  • 20. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D, Coste AT.
    Antimicrob Agents Chemother; 2016 Jan 24; 60(1):229-38. PubMed ID: 26482310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.